Macrothrombosis and stroke in patients with mild Covid‐19 infection

Coronavirus disease 2019 (COVID‐19) is a pandemic disease currently affecting millions of people worldwide. Its neurological implications are poorly understood, and further study is urgently required. A hypercoagulable state has been reported in patients with severe COVID‐19, but nothing is known ab...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 18; no. 8; pp. 2031 - 2033
Main Authors Fara, Michael G., Stein, Laura K., Skliut, Maryna, Morgello, Susan, Fifi, Johanna T., Dhamoon, Mandip S.
Format Journal Article
LanguageEnglish
Published England Elsevier Limited 01.08.2020
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Coronavirus disease 2019 (COVID‐19) is a pandemic disease currently affecting millions of people worldwide. Its neurological implications are poorly understood, and further study is urgently required. A hypercoagulable state has been reported in patients with severe COVID‐19, but nothing is known about coagulopathy in patients with milder disease. We describe cases of patients in New York City presenting with stroke secondary to large vessel thrombosis without occlusion, incidentally found to have COVID‐19 with only mild respiratory symptoms. This is in contrast to the venous thrombosis and microangiopathy that has been reported in patients with severe COVID‐19. Our cases suggest that even in the absence of severe disease, patients with COVID‐19 may be at increased risk of thrombus formation leading to stroke, perhaps resulting from viral involvement of the endothelium. Further systematic study is needed because this may have implications for primary and secondary stroke prevention in patients with COVID‐19.
Bibliography:Final decision: David Lillicrap and 23 May 2020
Manuscript handled by: David Lillicrap
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/jth.14938